Back to search
FDAFDA · Food and drugs·Recall number D-0513-2026

DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 2.5% DEX. LM/LC, 2L 5PK, Part Number 054-20222, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.

Published May 13, 2026 · Recall initiated: April 6, 2026

Summary

FDA records drug Class II recall D-0513-2026, published May 13, 2026 and initiated April 6, 2026. Recalling firm: Fresenius Medical Care Holdings, Inc.; Status: Ongoing; Reported quantity: 43,225 bags; Lot: Lots 25CU02002, 25CU02011, 25CU02012, 25CU02013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Holdings, Inc.
Distributor
Nationwide in the USA
Lot
Lots 25CU02002, 25CU02011, 25CU02012, 25CU02013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 2.5% DEX. LM/LC, 2L 5PK, Part Number 054-20222, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451. recalled?

Yes. FDA published recall D-0513-2026 on May 13, 2026. Reported hazard: Lack of Assurance of Sterility: Potential leaks from perforations in bags.

What should I do if I have this product?

Voluntary: Firm initiated · Letter